Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
allergan
biotech
clinical trials
life sciences
national blog main
alzheimer's disease
amgen
biohaven
boston
boston blog main
boston top stories
cgpr
crispr
cynthia collins
deals
editas medicine
eli lilly
europe blog main
fda
gene editing
leber congenital amaurosis type 10
merck
michelle robertson
migraine
national
national top stories
new york blog main
parkinson's disease
rare diseases
san francisco blog main
voyager therapeutics
What
medicines
2
×
treatment
2
×
abbvie
adults
allergan
alliance
approved
biotech
class
editas
editing
exits
experimental
fda
gene
genetic
migraine
monday
new
nod
pact
partnership
pill
pruning
research
returning
rights
terminated
treat
ubrelvy
ubrogepant
wins
Language
unset
2
×
Current search:
abbvie
×
unset
×
treatment
×
medicines
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines